Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1050
+0.0150 (16.67%)
Jun 30, 2026, 3:37 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 14.33 million as of July 1, 2026. Its market cap has decreased by -42.00% in one year.
Market Cap
14.33M
Enterprise Value
19.64M
Revenue
2.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 14.33M, a decrease of -77.53%. That is a compound annual growth rate of -17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 14.33M | -18.84% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 25.72M |
| Lobe Sciences | 25.57M |
| Pharmala Biotech Holdings | 15.24M |
| PreveCeutical Medical | 12.24M |
| Britannia Life Sciences | 12.17M |
| Hemostemix | 10.88M |
| Marvel Biosciences | 10.71M |
| COSCIENS Biopharma | 9.43M |